The Global Semaglutide Market Is Estimated To Grow Substantially Due To Increasing Prevalence Of Diabetes And Obesity
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes and obesity. It helps in controlling blood sugar levels …